According to the latest market research study released by Technavio, the global nucleic acid testing market is expected to grow at a CAGR of close to 10% during the forecast period 2016-2020.
This market research report by Technavio provides an in-depth analysis of the market in terms of revenue and emerging market trends. The report also includes an up-to-date analysis and forecasts for various market segments and all geographical regions.
Click here to request a free sample of this report
Technavio research analysts categorize the global nucleic acid testing market based on technology:
Global nucleic acid testing market shares by technology 2015
|
PCR |
70% |
|
SDA |
20% |
|
LCR |
5% |
|
Others |
5% |
Source: Technavio
The top three revenue contributing product segments are discussed below:
Global nucleic acid testing market by PCR
Polymerase chain reaction (PCR) had applications in molecular biology and used for the amplification of genetic material such as DNA/RNA. These devices are used for the diagnosis and detection of infectious diseases, paternity disputes, cancer and other genetic disorders. There are various types of PCRs systems available in the market that is are affordable and easy to handle in labs. Some of the systems available in the market are real-time (RT-PCR), quantitative real-time PCR (Q-RT-PCR), reverse transcriptase PCR (RT-PCR), multiplex PCR, and nested PCR. The companies are focusing on developing technology for disease management and drug discovery. The cost effectiveness and easy installations properties of these systems are driving further growth in the market.
“The low cost of this technology urges end-users such as hospitals, clinics, and research institutes to use these systems for the diagnostic purposes. The vendors are developing variants of this technology that helps to enable better accuracy and cost-effectiveness. PCR systems have user-friendly features that make it the most reliable method in molecular diagnostics compared to other systems that are available in the market,” says Srinivas Sashidhar, a lead analyst at Technavio for research on in-vitro diagnostics.
Global nucleic acid testing market by SDA
Strand displacement amplification (SDA) involves isothermal nucleic acid amplification used in molecular diagnostics. This diagnosis is performed before the hybridization process and is a defined sequence process where the sequence is unique to the target. The isothermal nucleic acid testing is used for the amplification of genetic fragments that requires fast processing time and that delivers very precise results. The various isothermal based amplification processes are Loop-mediated isothermal amplification (LAMP), Helicase-dependent amplification (HDA) and Nicking enzyme amplification reaction (NEAR). The elimination of thermocycler from the system makes it one of the cost-effective technologies that are preferred by the hospitals, clinics, and research institutes for the diagnostics purpose. The thermocycler helps in maintaining the correct temperature for the enzymes being used during the process. The pharma companies are developing efficient systems that help in reducing the cost of the equipment and procedure.
Global nucleic acid testing market by LCR
Ligase chain reaction (LCR) process includes two of the major enzymes- ligase and polymerase and in each cycle, the target nucleic acid molecule doubles. These devices help minimize the target-independent ligation and aids in avoiding the need for fresh ligase at every step. This process is highly accurate as the nucleotide allows for higher discriminatory power against the mismatches at a single site. The technology is commonly used for the detection of single base mutations, especially in genetic diseases. Nucleotide amplification has made LCR more specific and sensitive molecular diagnosis technique which in turn, will boost the sale of these products during the forecast period.
The top leading vendors operating in the global nucleic acid testing market are:
- Abbott Laboratories
- Roche Molecular Systems
- Siemens Healthineers
- Hologic
- Qiagen
Other prominent vendors in the market include Accriva Diagnostics, Acon Laboratories, Affymetrix, Ahram Biosystem, Asuragen, Biocartis, Bio-Rad Laboratories, Cepheid, DiagCor, EKF Diagnostics, Erba Diagnostics, and Randox Laboratories.
A more detailed analysis is available in the Technavio report titled, ‘Global Nucleic Acid Testing Market 2016-2020’. Technavio also customizes reports by other regions and specific segments upon request.
Other related reports:
- Global Blood Stream Infection Testing Market 2016-2020
- Global Enteric Disease Testing Market 2016-2020
- Global Professional Diagnostics Market 2016-2020
To read more press releases- click here.
For any assistance or query, please contact our media team at:
media@technavio.com
US: +1 630 333 9501
UK: +44 208 123 1770
www.technavio.com
